Antithrombotic Therapy in Children-Reference-Cited by-同舟云学术

Antithrombotic Therapy in Children

Published:2001-01 Issue:1 Volume:119 Page:344S-370S
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Monagle Paul,Michelson Alan D.,Bovill Edward,Andrew Maureen

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference350 articles.

1. Oral anticoagulant therapy in pediatric patients: a prospective study;Andrew;Thromb Haemost,1994

2. Home monitoring of warfarin therapy in children with a whole blood prothrombin time monitor;Massicotte;J Pediatr,1995

3. Antithrombotic therapy in children;Michelson;Chest,1995

4. Supranormalizing antithrombin levels is safe in children with acute lymphoblastic leukemia treated with L-asparaginase: results of the PARKAA study [abstract];Mitchell;Blood,1999

5. A prospective cohort determining the incidence of thrombotic events in children with acute lymphoblastic leukemia treated with L-asparaginase: results of the PARKAA study [abstract];Mitchell;Blood,1999

Cited by 227 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterizing Enoxaparin’s Population Pharmacokinetics to Guide Dose Individualization in the Pediatric Population;Clinical Pharmacokinetics;2024-07

2. Evaluating Anticoagulant and Antiplatelet Therapies in Rhesus and Cynomolgus Macaques for Predictive Modeling in Humans;Surgeries;2024-05-17

3. Enoxaparin treatment dosing for venous thromboembolism in pediatric patients with obesity;Pediatric Blood & Cancer;2024-05-03

4. Evaluation of the Safety and Efficacy of Enoxaparin Once-Daily Versus Twice-Daily Dosing for Prophylaxis in Pediatric Patients;The Journal of Pediatric Pharmacology and Therapeutics;2024-04-01

5. Risk factors for serious adverse events related to vitamin K antagonists in children with congenital or acquired heart disease: a prospective cohort study;Thrombosis Research;2023-12